| LLY |
Eli Lilly and Company |
0 |
5.39% |
|
|
|
|
|
N/A |
0.00% |
44.40% |
42.16% |
|---|
| PFE |
Pfizer Inc. |
0 |
5.28% |
|
|
|
|
|
N/A |
0.00% |
28.08% |
21.11% |
|---|
| ABBV |
AbbVie Inc. |
0 |
5.22% |
|
|
|
|
|
N/A |
0.00% |
24.36% |
14.55% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
5.12% |
|
|
|
|
|
N/A |
0.00% |
28.04% |
24.62% |
|---|
| BMY |
Bristol-Myers Squibb Company |
0 |
5.09% |
|
|
|
|
|
N/A |
0.00% |
29.50% |
23.55% |
|---|
| ABT |
Abbott Laboratories |
0 |
5.05% |
|
|
|
|
|
N/A |
0.00% |
20.38% |
14.29% |
|---|
| JNJ |
Johnson & Johnson |
0 |
4.83% |
|
|
|
|
|
N/A |
0.00% |
19.70% |
20.31% |
|---|
| AMGN |
Amgen Inc. |
0 |
4.64% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
3.22% |
|
|
|
|
|
N/A |
0.00% |
62.46% |
39.19% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.95% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
0 |
2.92% |
|
|
|
|
|
N/A |
0.00% |
97.22% |
55.52% |
|---|
| LQDA |
Liquidia Corporation |
0 |
2.91% |
|
|
|
|
|
N/A |
0.00% |
99.04% |
60.84% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
0 |
2.84% |
|
|
|
|
|
N/A |
0.00% |
59.90% |
101.22% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
79.15% |
69.17% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
2.77% |
|
|
|
|
|
N/A |
0.00% |
58.67% |
104.61% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.70% |
|
|
|
|
|
N/A |
0.00% |
28.33% |
18.82% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
2.69% |
|
|
|
|
|
N/A |
0.00% |
1,029.44% |
4.35% |
|---|
| COLL |
Collegium Pharmaceutical, Inc. |
0 |
2.68% |
|
|
|
|
|
N/A |
0.00% |
180.38% |
39.47% |
|---|
| VTRS |
Viatris Inc. |
0 |
2.65% |
|
|
|
|
|
N/A |
0.00% |
36.13% |
41.13% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
2.64% |
|
|
|
|
|
N/A |
0.00% |
451.62% |
28.28% |
|---|
| OCUL |
Ocular Therapeutix, Inc. |
0 |
2.63% |
|
|
|
|
|
N/A |
0.00% |
68.93% |
37.98% |
|---|
| ANIP |
ANI Pharmaceuticals, Inc. |
0 |
2.63% |
|
|
|
|
|
N/A |
0.00% |
59.22% |
83.79% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
111.53% |
44.23% |
|---|
| INVA |
Innoviva, Inc. |
0 |
2.59% |
|
|
|
|
|
N/A |
0.00% |
817.11% |
64.67% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
0 |
2.56% |
|
|
|
|
|
N/A |
0.00% |
39.12% |
27.88% |
|---|
| PRGO |
Perrigo Company plc |
0 |
2.55% |
|
|
|
|
|
N/A |
0.00% |
103.01% |
61.71% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
0 |
2.52% |
|
|
|
|
|
N/A |
0.00% |
42.07% |
19.56% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
56.31% |
49.77% |
|---|
| GERN |
Geron Corporation |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
354.23% |
31.50% |
|---|
| AGPXX |
Invesco Government & Agency Portfolio |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|